The effect of methylphenidate on attention in acquired brain injury as recorded by useful field of view

Journal of Applied Research

Volumn 5, Issue 1, 2005, Pages 61-72

  Al Adawi, Samir ^a,b   Calvanio, Ron ^b   Dorvlo, Atsu S S ^a   Costa, Russell E ^b   Mello, Jennifer J ^b   Huynh, Charlie C ^b   Shah, Mrugeshkumar K ^b   Chae, Heechin ^b   Burke, David T ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Acquired brain injury; Methylphenidate; Subarachanoid hemorrhage; Traumatic brain injury; Useful Field of View

Indexed keywords

METHYLPHENIDATE;

ADULT; AGED; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN INJURY; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DIVIDED ATTENTION; FEMALE; FUNCTIONAL IMPAIRMENT MEASURE; HOSPITAL PATIENT; HUMAN; MALE; SCORING SYSTEM; SELECTIVE ATTENTION; USEFUL FIELD OF VIEW; VISION;

EID: 17044413190     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rao V, Lyketsos, CG. Psychiatric aspects of traumatic brain injury. Psychiatr Clin North Am. 2002;25:43-69.
2. Chan RCK. Attentional deficits in patients with postconcussion symptoms: a componential perspective. Brain Inj. 2001;15:71-94.
3. Kaelin DL, Cifu DX, Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehabil. 1996;77:6-9.
4. Wroblewski BA, Glenn MB. Pharmacological treatment of arousal and cognitive deficits. J Head Trauma Rehabil. 1994;9:19-42.
5. Bate AJ, Mathias JL, Crawford JR. Performance on the test of everyday attention and standard tests of attention following severe traumatic brain injury. Clin Neuropsychol. 2001;15:405-422.
6. Kitcher P. Patients in the 21st century: The impact of predictive medicine. Great issues for medicine in the twenty-first century. Ann N Y Acad Sci. 1999;882:142-149.
7. Ball K, Roenker DL, Bruni JR. Developmental changes in attention and visual search throughout adulthood. In: Enns J, ed. Advances in Psychology. Amsterdam, Netherlands: North-Holland-Elsevier Science Publishers; 1990:489-508.
8. Sims RV, McGwin G, Allman RM, et al. Exploratory study of incident vehicle crashes among older drivers. J Gerontol A-Biol. 2000;55:M22-M27.
9. Goode KT, Ball KK, Sloane M, et al. Useful field of view and other neurocognitive indicators of crash risk in older adults. J Clin Psychol Med. 1998;5:425-440.
10. Owsley C, Ball K, McGwin G, et al. Visual processing impairment and risk of motor vehicle crash among older adults. JAMA. 1998;279:1083-1088.
11. Schneider JJ, Novack TA, Alderson A, et al. UFOV risk level and driving ability in patients with traumatic brain injury. Arch Clin Neuropsychol. 2002;15:658-658.
12. Lengenfelder J, Schultheis MT, Al-Shibabi T, et al. Divided attention and driving: A pilot study using virtual reality technology. J Head Trauma Rehabil. 2002;17:26-37.
13. Mazer BL, Sofer S, Korner-Bitensky N, et al. Use of the UFOV to evaluate and retrain visual attention skills in clients with stroke: A pilot study. Am J Occup Ther. 2001;55:552-557.
14. Fisk GD, Novack T, Mennemeier M, Roenker D. Useful field of view after traumatic brain injury. J Head Trauma Rehabil. 2002;17:16-25.
15. Fisk GD, Owsley C, Mennemeier M. Vision, attention, and self-reported driving behaviors in community-dwelling stroke survivors. Arch Phys Med Rehabil. 2002;83:469-477.
16. Whyte J, Hart T, Schuster K, et al. Effects of methylphenidate on attentional function after traumatic brain injury-A randomized, placebo-controlled trial. Am J Phys Med. 1997;76:440-450.
17. Santosh PJ, Taylor E. Stimulant drugs. Eur Child Adolesc Psychiatry. 2002;9(suppl 1):27-43.
18. Al-Adawi S, Dawe GS, Al-Hussaini AA. Aboulia: neurobehavioural dysfunction of dopaminergic system. Med Hypotheses. 2000;54:523-530.
19. Yang SY, Zhang S, Wang ML. Clinical significance of admission hyperglycaemia and factors related to it in patients with acute severe head injury. Surg Neurol. 1995;44:373-377.
20. Basavappa S, Mobasheri A, Errington R, et al. Inhibition of Na+, K+-ATPase activates swelling-induced taurine efflux in a human neuroblastoma cell line. J Cell Physiol. 1998;174:145-153.
21. Zhou QY, Quaife CJ, Palmiter RD. Targeted disruption of the tyrosine-hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature, 1995;374:640-643.
22. Carson RP, Robertson D. Genetic manipulation of noradrenergic neurons. J Pharmacol Exp Ther. 2002;301:410-417.
23. Braha RED, Joyce BM, Smith LS. Ritalin and neurobehavioural therapy in the treatment of low arousal following severe brain injury. Neurorehabilitation. 1999;12:201-204.
24. Glenn MB. Methylphenidate for cognitive and behavioral dysfunction after traumatic brain injury. J Head Trauma Rehabil. 1998;13:87-90.
25. Calvanio R, Williams R, Burke TD, Mello J, Lepak P, Al-Adawi S, Shah M K. Acquired brain injury, visual attention, and the useful field of view test: a pilot study. Arch Phys Med Rehabil. 2004;85:474-478.
26. Lundblad M, Andersson M, Winkler C, et al. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci. 2002;15:120-132.
27. West CG, Gildengorin G, Haegerstrom-Portnoy G, Schneck ME, Lott L, Brabyn JA. Is vision function related to physical functional ability in older adults? J Am Geriatr Soc. 2002;50:136-145.
28. Guide for the Uniform Data System for Medical Rehabilitation (Adult FIM). Version 4.0. Buffalo, NY: State University of New York at Buffalo; 1995.
29. Powell JH, AlAdawi S, Morgan J, Greenwood RJ. Motivational deficits after brain injury: Effects of bromocriptine in 11 patients. J Neurol Neurosurg Psychiatry. 1996;60:416-421.
30. Teasdale GM, Jennett B. Assessment of coma and impaired consciousness: practical scale. Lancet. 1974;2:81-84.
31. Challman,TD, Lipsky, JJ. Methylphenidate: Its pharmacology and uses. Mayo Clin Proc. 2002;75:711-721.
32. Ball KK, Beard BL, Roenker DL, et al. Age and visual-search-expanding the useful field of view. J Opt Soc Am A. 1988;5:2210-2219.
33. Wright J, Bushnik T, O'Hare P. The Center for Outcome Measurement in Brain Injury (COMBI): An Internet resource you should know about. J Head Trauma Rehabil. 2000;15:734-738.
34. Huang ME, Cifu CX, Keyser-Marcus L. Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury. Am J Phys Med Rehabil. 2000;79:327-335.
35. StatXact 5. Cambridge, Mass: Cytel Software Corporation; 2001.
36. Sprent P, Smeeton NC. Applied nonparametric statistical methods. New York, NY: Chapman and Hall/CRC; 2001:212.
37. Mills KC, Spruill SE, Kanne RW, Parkman KM, Zhang Y. The influence of stimulants, sedatives, and fatigue on tunnel vision: Risk factors for driving and piloting. Hum Factors. 2001;43:310-327.
38. Burke DT, Calvanio R, Kim H, et al. Useful field of view for attention analysis in traumatic brain injury [Abstract]. Arch Phys Med Rehabil. 1999;80:1194.
39. Sharrack B, Hughes RAC, Soudain S, et al. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain. 1999;122(Part 1):141-159.
40. Calvanio, R, Burke, DT, Kim HJ et al. Useful field of view as a measure of attention impairment in TBI patients [Abstract]. Am J Phys Med Rehabil. 2000;79:215.
41. Meakin CJ. Screening for depression in the medically ill-the future of paper and pencil Tests. Br J Psychiatry. 1992;160:212-216.
42. Piguet O, King AC, Harrison DP. Assessment of minimally responsive patients: clinical difficulties of single-case design. Brain Inj. 1999;13:829-837.